Akso Health Group Stock Revenue

AHG Stock  USD 0.80  0.05  5.88%   
Akso Health Group fundamentals help investors to digest information that contributes to Akso Health's financial success or failures. It also enables traders to predict the movement of Akso Stock. The fundamental analysis module provides a way to measure Akso Health's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Akso Health stock.
Last ReportedProjected for Next Year
Total Revenue2.4 M2.3 M
Research And Ddevelopement To Revenue is expected to grow at the current pace this year, while Current Deferred Revenue is projected to decrease to roughly 232.3 K.
  
This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

Akso Health Group Company Revenue Analysis

Akso Health's Revenue is income that a firm generates from business activities such us rendering services or selling goods to customers. It is a crucial part of a business and an essential item when evaluating a company's financial statements. Revenues from a firm's primary business operations can be reported on the income statement as sales revenue, net sales, or simply sales, depending on the industry in which a given company operates.

Revenue

 = 

Money Received

-

Discounts and Returns

More About Revenue | All Equity Analysis

Current Akso Health Revenue

    
  2.41 M  
Most of Akso Health's fundamental indicators, such as Revenue, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Akso Health Group is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.

Historical and Projected quarterly revenue of Akso

Projected quarterly revenue analysis of Akso Health Group provides investors and stakeholders with an insight into the company's performance and growth prospects. When actual revenues of Akso Health match or exceed analyst estimates, it positively influences investor confidence and market perception, often leading to a rise in Akso Health's stock price.

Akso Revenue Driver Correlations

Understanding the fundamental principles of building solid financial models for Akso Health is extremely important. It helps to project a fair market value of Akso Stock properly, considering its historical fundamentals such as Revenue. Since Akso Health's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Akso Health's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Akso Health's interrelated accounts and indicators.

Akso Revenue Historical Pattern

Today, most investors in Akso Health Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Akso Health's growth ratios. Consistent increases or drops in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's revenue growth rates may not be enough to decide which company is a better investment. That's why investors frequently use a static breakdown of Akso Health revenue as a starting point in their analysis.
   Akso Health Revenue   
       Timeline  
Revenue is typically recorded when cash or cash equivalents are exchanged for services or goods and can include products or services discounts, promotions, as well as early payments on invoices or services rendered in advance.
Competition

Akso Current Deferred Revenue

Current Deferred Revenue

232,321

At this time, Akso Health's Current Deferred Revenue is most likely to increase significantly in the upcoming years.
Based on the latest financial disclosure, Akso Health Group reported 2.41 M of revenue. This is 99.98% lower than that of the Health Care Equipment & Supplies sector and 99.96% lower than that of the Health Care industry. The revenue for all United States stocks is 99.97% higher than that of the company.

Akso Revenue Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Akso Health's direct or indirect competition against its Revenue to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Akso Health could also be used in its relative valuation, which is a method of valuing Akso Health by comparing valuation metrics of similar companies.
Akso Health is currently under evaluation in revenue category among its peers.

Akso Health Current Valuation Drivers

We derive many important indicators used in calculating different scores of Akso Health from analyzing Akso Health's financial statements. These drivers represent accounts that assess Akso Health's ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of Akso Health's important valuation drivers and their relationship over time.
201920202021202220232024 (projected)
Market Cap176.7M20.5M33.6M8.1M51.3M48.8M
Enterprise Value139.4M30.3M48.9M9.9M(31.8M)(30.2M)

Akso Health Institutional Holders

Institutional Holdings refers to the ownership stake in Akso Health that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of Akso Health's outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Akso Health's value.
Shares
Renaissance Technologies Corp2024-09-30
152.6 K
Ubs Group Ag2024-06-30
18.3 K
Geode Capital Management, Llc2024-09-30
15 K
Rhumbline Advisers2024-06-30
14.3 K
Millennium Management Llc2024-06-30
14.2 K
Xtx Topco Ltd2024-06-30
0.0

Akso Fundamentals

About Akso Health Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Akso Health Group's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Akso Health using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Akso Health Group based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.

Currently Active Assets on Macroaxis

When determining whether Akso Health Group is a strong investment it is important to analyze Akso Health's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Akso Health's future performance. For an informed investment choice regarding Akso Stock, refer to the following important reports:
Check out Akso Health Piotroski F Score and Akso Health Altman Z Score analysis.
You can also try the Portfolio Comparator module to compare the composition, asset allocations and performance of any two portfolios in your account.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Akso Health. If investors know Akso will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Akso Health listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(0.21)
Revenue Per Share
0.051
Quarterly Revenue Growth
0.148
Return On Assets
(0.07)
Return On Equity
(0.12)
The market value of Akso Health Group is measured differently than its book value, which is the value of Akso that is recorded on the company's balance sheet. Investors also form their own opinion of Akso Health's value that differs from its market value or its book value, called intrinsic value, which is Akso Health's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Akso Health's market value can be influenced by many factors that don't directly affect Akso Health's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Akso Health's value and its price as these two are different measures arrived at by different means. Investors typically determine if Akso Health is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Akso Health's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.